What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?
| Data(s) |
2008
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_82029D955FF2 isbn:1534-6080[electronic], 0041-1337[linking] pmid:19005418 doi:10.1097/TP.0b013e3181890788 isiid:000260945600026 |
| Idioma(s) |
en |
| Fonte |
Transplantation, vol. 86, no. 9, pp. 1323-1324 |
| Palavras-Chave | #Adult; Antiviral Agents/therapeutic use; Case-Control Studies; Cytomegalovirus Infections/epidemiology; Cytomegalovirus Infections/prevention & control; Follow-Up Studies; Ganciclovir/analogs & derivatives; Ganciclovir/therapeutic use; Humans; Incidence; Kidney Transplantation; Opportunistic Infections/epidemiology; Opportunistic Infections/prevention & control |
| Tipo |
info:eu-repo/semantics/article article |
